A combination preparation containing BPC-157, TB-500 (thymosin β4 fragment), GHK-Cu, and KPV (Lys-Pro-Val, the C-terminal tripeptide of α-MSH). Each has been examined separately in preclinical models — for angiogenic signalling, cell migration, extracellular matrix remodelling, and melanocortin signalling respectively. Component purities determined individually by HPLC; COA supplied with every batch. For laboratory research use only. Not for human consumption.